Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|April 7, 2009
Replicative potential of human natural killer cellsHiroyuki Fujisaki, Harumi Kakuda, Chihaya Imai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2025
[Progressive multifocal leukoencephalopathy developed 3 years after related HLA-haploidentical peripheral blood stem cell transplantation]Kumiko Ando, Kazuo Nakamichi, Kiyoharu Hirose, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2017
[Congenital leukemia showing lineage switch following induction chemotherapy and attaining long-term remission after HLA-haploidentical stem cell transplantation]Kazuki Furudate, Yuri Okimoto, Kumiko Ando, et al.
Experimental Hematology|July 28, 2007
Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signalVirna Marin, Harumi Kakuda, Erica Dander, et al.
International Journal of Hematology|July 14, 2024
Trametinib for a child with refractory Rosai-Dorfman-Destombes disease harboring a novel somatic mutation in MAP2K1Yuichi Taneyama, Akira Morimoto, Hidemasa Ochiai, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|November 2, 2021
A questionnaire study of support for adult survivors of childhood cancerKazuki Terada, Harumi Kakuda, Naomi Iida, et al.
Cancer Research|April 23, 2009
Expansion of highly cytotoxic human natural killer cells for cancer cell therapyHiroyuki Fujisaki, Harumi Kakuda, Noriko Shimasaki, et al.
Pediatric Blood & Cancer|December 10, 2022
A nationwide survey of late effects in survivors of juvenile myelomonocytic leukemia in JapanShuichi Ozono, Kazuo Sakashita, Nao Yoshida, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 19, 2019
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitorsRie Shirayama, Hideyuki Takedani, Yushi Chikasawa, et al.
International Journal of Hematology|December 16, 2014
Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalanMiharu Yabe, Yoshitoshi Ohtsuka, Kenichiro Watanabe, et al.
Pageof 3